TrialRMD open2024

Long-term efficacy of a 2-year MRI treat-to-target strategy on disease activity and radiographic progression in patients with rheumatoid arthritis in clinical remission: 5-year follow-up of the IMAGINE-RA randomised trial.

Signe Møller-Bisgaard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.